FDA Investigator William E Keer
William E Keer has conducted inspections on 314 sites in 1 countries as of 17 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
314
Last Inspection Date:
17 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with William E Keer:
Aaron L Dunbar,
Aimee J Edwin,
Alecia L Marson,
Alfred P Pistorio,
Alison A Nicoli,
Amy L Mcintyre,
Ana M Placencia,
Anthony J Ladner,
Bing Lin,
Boun M Xiong,
Bradley A Servais,
Brian E Thompson,
Brian L Szcyubialka,
Carolyn A Warren,
Catherine M Vanderhoef,
Charles R Cote, RIC,
Christina A Castineyra,
Corey K Reno,
Courtney R Ingalsbe,
Courtney R Tiegs,
Dacia E Quick,
Dale A Nyberg,
Darlene L Krieger,
Darren D Holaday,
David B Wieneke,
David J Leray,
Demetria L Lueneburg,
Diane T Reindl,
Dianna C Sonnenburg,
Douglas J Snyder,
Edward A Fabiano,
Elizabeth P Mayer,
Emily E Harlow,
Emily E Markgraf,
Eric A Breselow,
Fannie M Harrell,
Frank S Sedzielarz,
Frederick J Tillman,
Gina M Scholze,
Grant M Ruis,
Gregory W Smith,
Heather Akleimola Hulbert,
Howard A Burmester,
Ivan E Reyes,
J Benedict,
Jaclyn N Munsch,
Jacob W Reynolds,
Jake T Lane,
James I Jahr,
James K Ireland,
Jamie R Thompson,
Jane E Nelson,
Janis R Armedoriz,
Jasjeet K Sekhon,
Jean M Bosenbecker,
Jennifer A Longie Vollom,
Jennifer Guttuso,
Jennifer R Mathern,
Jeremy L Tri,
Jesse P Romenesko,
Jessica L Barr,
Jessica M Novak,
Joel D Hustedt,
John P Hermann,
Jon C Polzine,
Julie Woodberry,
Justin A Boyd,
Karen M Labounty,
Karla J Youngberg,
Katherine A Clarke Girolamo,
Kathryn M Mogen,
Kawshalya Pathiraja,
Kellie L Thommes, RN,
Kenneth A Libertoski,
Kevin L Torgerson,
Khin Mang U, MD,
Kibily D Dembele,
Kimberly W Destromp,
Krista K Petersen,
Kristy E Zuroski,
Kyle J Mccracken,
Larae M Koopman,
Lauren E Merz,
Lauren E Sanger,
Leonardm,
Lillian C Hsu,
Linda V Weyer,
Lisa M Lopez,
Mada A Tautges,
Margaret M Lubbers Solberg,
Marie A Fadden,
Mary R Chestolowski,
Melanie C Voges,
Melissa D Kalik,
Melissa I Michurski,
Mohammed H Adam,
Nicholas J Dubrovin,
Nicholas S Vasilakes,
Nicole C Shokatz,
Paola E Lathrop,
Patrick E Gainer,
Patrick J Campbell,
Peter T Erlandson,
Rebecca L Caulfield,
Rebecca L Keller,
Rebecca L Mullikin,
Rebecca L Zamora,
Richard Jay Tucker, RS,
Richard W Koller,
Robert H Claflin,
Robert J Waldorf,
Ronald R Ruff,
Rostislav Servetnyk,
Sana A Elassar,
Sarah A Palmer,
Scott A Golladay,
Scott L Schenian,
Seth A Abbott,
Sharon L Matson,
Shaun M Olson,
Steven A Skaar,
Susan M Miller,
Suzanne M Crotty,
Tanya L Keigley,
Tara C Singh,
Tara M Carolfi,
Theresa C Klaman,
Thomas S Donaldson,
Tony T Yang,
Troy A Brenny,
Tyson J Eldridge Stedman,
Victoria L Palmer,
Wayne W Grundstrom,
Wendy L Trefethren Grang,
William P Fournier,
Zachary P Wachlarowicz
William E Keer's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2002 | EIR | Foremost Farms USA, Cooperative - EIR, 2002-09-11 |
August, 2001 | EIR | Foremost Farms USA, Cooperative - EIR, 2001-10-03 |
December, 2001 | FDA 483 | Allen , Dr. Mark S. - Form 483, 2001-12-06 |
April, 2000 | EIR | Wiesner, Russell H., M.D., Clinical Investigator - EIR, 2000-04-18 |
June, 2001 | FDA 483 | St. Mary's Hospital, Non-clinical Laboratory - Form 483, 2001-06-20 |
August, 2000 | FDA 483 | Dr. James V. Donadio - Form 483, 2000-08-25 |
June, 2001 | EIR | Hayes, Dr. David L. - EIR, 2001-06-20 |
January, 2003 | FDA 483 | Steuart Laboratories - Form 483, 2003-01-08 |
August, 2000 | EIR | Dr. James V. Donadio - EIR, 2000-08-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more